AME Logo
PKD

Prasanta Kumar Dash

University of Nebraska Medical Center (UNMC), United States

Biography

Prasanta Kumar Dash, Ph.D., is an Associate Professor in the Department of Pharmacology and Experimental Neuroscience at the University of Nebraska Medical Center (UNMC). His research focuses on HIV persistence and cure strategies, HIVassociated aging, neuroimmune dysfunction, and translational animal models of infectious and neurodegenerative diseases. Dr. Dash has maintained continuous NIH funding since 2019 and serves as Principal Investigator or Co-Investigator on multiple NIH-funded projects investigating HIV reservoirs, viral latency, neurocognitive impairment, cardiovascular comorbidities, and aging-related changes in the central nervous system. He is internationally recognized for pioneering studies demonstrating HIV-1 elimination in humanized mouse models using long-acting antiretroviral therapy combined with CRISPR-Cas9 gene editing, work highlighted by the NIH Director’s Blog and Nature. Dr. Dash has authored more than 50 peer-reviewed publications, including articles in Nature Communications, PNAS, Journal of Extracellular Vesicles, Molecular Neurodegeneration, Communications Biology, AIDS, and The Journal of Neuroscience, with over 10 publications as corresponding author. He has also authored invited editorials in AIDS and contributed book chapters on HIV pathogenesis and therapeutics. In addition to his research, he is actively engaged in mentoring, teaching, scientific peer review, and professional service, currently serving as Membership Chair of the Society on NeuroImmune Pharmacology (SNIP). Dr. Dash has received multiple national and international honors, including several Young Investigator Awards from the Conference on Retroviruses and Opportunistic Infections (CROI), New Investigator award from UNMCand is a frequent invited speaker at scientific conferences worldwide.